Medical Decisions Empowered by Genetics

ASCO's New PARPi Guideline Exclusively Cites myChoice CDx

Revolutionizing Patient Care

For over 25 years Myriad has been revolutionizing how to approach cancer treatment. Being one of the first companies to study and discover the BRCA 1/2 gene association with breast and ovarian cancer, Myriad has been a pioneer for the landscape of patient care.

Myriad Oncology's Tests Are

Affordable

3 out of 4 patients pay $0 due to excellent coverage and assistance

accurate

Industry-leading accuracy so you can feel confident in your patients’ results

secure

Unlike some labs, Myriad will never sell your patients’ personal or genetic information

simple

Myriad makes genetic testing simple with clear, actionable results

explore cancer types

Click the cancer type below to learn more.

Provider
Blog

Click below to see our blog and learn more about provider resources.

Provider
Resources

Click below view and explore our provider resources.